Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Spray for Pain Control During IUD Insertion
NCT03870711Phase 4Completed
- Sponsor
- Mahidol University
- Start
- Aug 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine 10% oropharyngeal spray in procedural pain (2 arms), sponsored by Mahidol University. Primary endpoint: Visual Analog Scale Pain Score. Started Aug 2018; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT03870711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03870711.